138 results
Page 5 of 7
8-K
EX-99.1
5o6nvxhzahixt7d2xm
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
EX-99.1
z9paf o06y32
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
stcm59l 3m
8 Aug 19
Fibrogen Reports Second Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
1y77ms oo
24 Jul 19
Other Events
9:46pm
8-K
EX-99.2
j91zm
24 Jul 19
Other Events
9:46pm
8-K
EX-99.1
yva7c0o7fuptn5uu5qa
22 Jul 19
Other Events
8:00am
8-K
EX-99.1
0bryqdxk tpomrx443
5 Jun 19
Fibrogen Appoints Suzanne Blaug to Board of Directors
5:15pm
8-K
EX-99.1
flv0ci4q
9 May 19
Fibrogen Reports First Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
apldj
15 Apr 19
Other Events
9:00am
8-K
EX-99.1
0u5ixo2s uz
27 Feb 19
Fibrogen Reports Fourth Quarter and Full Year 2018 Financial Results
12:00am
8-K
EX-99.1
69ew6
7 Jan 19
Regulation FD Disclosure
8:52am
8-K
EX-99.1
ilobot85hjg
20 Dec 18
FibroGen Announces Positive Topline Results from Three Global Phase 3
8:30am
8-K
EX-99.1
e2ixti j1k
18 Dec 18
FibroGen Announces Approval of Roxadustat in China for the Treatment of
12:00am
8-K
EX-99.1
2oe7w u5hpt4lo0q
6 Dec 18
Fibrogen Appoints Maykin Ho, PH.D., to Board of Directors
6:09am
8-K
EX-99.1
ommdq 4ag
8 Nov 18
FIBROGEN REPORTS third QUARTER 2018 FINANCIAL RESULTS
4:05pm